Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

NCT01182350 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
53
Enrollment
OTHER
Sponsor class

Stopped Per design: Stop if fewer than 3 cohorts by molecular classification were with 10 participants or only 1 cohort enrolled at least 15 participants of 50.

Conditions

Interventions

Sponsor

Karen D. Wright MD

Collaborators